Information Provided By: 
Fly News Breaks for January 22, 2020
CNCE
Jan 22, 2020 | 13:53 EDT
JMP Securities analyst Liisa Bayko raised her price target on shares of Concert Pharmaceuticals after the company announced that it has received a USPTO notice of allowance for a patent related to CTP-543, the company's alopecia areata treatment. The new composition of matter patent provides protection from generic competition until at least 2037, which significantly prolongs the revenue tail for CTP-543, said Bayko, who keeps an Outperform rating on Concert shares.
News For CNCE From the Last 2 Days
There are no results for your query CNCE
